Improvement in right ventricular function during reversibility testing in pulmonary arterial hypertension: a case report

被引:0
作者
Sandrine Huez
Jean-Luc Vachiéry
Robert Naeije
机构
[1] Hôpital Erasme,Department of Cardiology
[2] Université Libre de Bruxelles,Department of Pathophysiology
[3] Erasmus Campus,undefined
来源
Cardiovascular Ultrasound | / 7卷
关键词
Nitric Oxide; Right Ventricular; Pulmonary Arterial Hypertension; Tissue Doppler Imaging; Iloprost;
D O I
暂无
中图分类号
学科分类号
摘要
A right heart catheterization with reversibility testing is recommended for the diagnosis and treatment of pulmonary arterial hypertension. In this 24 years-old woman, the inhalation of 5 μg iloprost transiently decreased mean pulmonary artery pressure from 62 to 36 mmHg and pulmonary vascular resistance from 11.0 to 4.9 Wood units, meeting the criteria of a "positive response". The echocardiographic examination showed normalization of right heart chamber dimensions and of the right ventricular performance (Tei) index. Pulsed tissue Doppler imaging of the right ventricle showed a decrease in the isovolumic relaxation time from 102 to 73 ms, and an increase of the E/A ratio from 0.72 to 1.38, together with marked improvements in mid-apical free wall systolic strain and strain rate. A positive response to reversibility testing of pulmonary arterial hypertension may be associated with quasi normalization of right ventricular function, in spite of still elevated pulmonary artery pressure.
引用
收藏
相关论文
共 50 条
  • [31] Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension
    Ghio, Stefano
    Klersy, Catherine
    Magrini, Giulia
    D'Armini, Andrea Maria
    Scelsi, Laura
    Raineri, Claudia
    Pasotti, Michele
    Serio, Alessandra
    Campana, Carlo
    Vigano, Mario
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 (03) : 272 - 278
  • [32] Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease
    Fournier, Emmanuelle
    Selegny, Maelle
    Amsallem, Myriam
    Haddad, Francois
    Cohen, Sarah
    Valdeolmillos, Estibaliz
    Le Pavec, Jerome
    Humbert, Marc
    Isorni, Marc -Antoine
    Azarine, Arshid
    Sitbon, Olivier
    Jais, Xavier
    Savale, Laurent
    Montani, David
    Fadel, Elie
    Zoghbi, Joy
    Belli, Emre
    Hascoet, Sebastien
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (05): : 333 - 343
  • [33] Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension
    Badagliacca, Roberto
    Raina, Amresh
    Ghio, Stefano
    D'Alto, Michele
    Confalonieri, Marco
    Correale, Michele
    Corda, Marco
    Paciocco, Giuseppe
    Lombardi, Carlo
    Mule, Massimiliano
    Poscia, Roberto
    Scelsi, Laura
    Argiento, Paola
    Sciomer, Susanna
    Benza, Raymond L.
    Vizza, Carmine Dario
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03) : 365 - 375
  • [34] Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension
    Kwan, Ethan D.
    Hardie, Becky A.
    Garcia, Kristen M.
    Mu, Hao
    Wang, Tsui-Min
    Valdez-Jasso, Daniela
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (02): : H351 - H363
  • [35] Right ventricular systolic function in patients with pulmonary hypertension
    Tazar, Jorge
    del Pilar Haurigot, Maria
    Caram, Roberto
    Caram, Roberto
    Haurigot, Gustavo E.
    INSUFICIENCIA CARDIACA, 2012, 7 (03) : 109 - 116
  • [36] Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function
    Mina Kawamukai
    Akiyoshi Hashimoto
    Masayuki Koyama
    Nobutaka Nagano
    Junichi Nishida
    Atsushi Mochizuki
    Hidemichi Kouzu
    Atsuko Muranaka
    Nobuaki Kokubu
    Daigo Nagahara
    Satoshi Yuda
    Kazufumi Tsuchihashi
    Tetsuji Miura
    Heart and Vessels, 2019, 34 : 1789 - 1800
  • [37] Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function
    Kawamukai, Mina
    Hashimoto, Akiyoshi
    Koyama, Masayuki
    Nagano, Nobutaka
    Nishida, Junichi
    Mochizuki, Atsushi
    Kouzu, Hidemichi
    Muranaka, Atsuko
    Kokubu, Nobuaki
    Nagahara, Daigo
    Yuda, Satoshi
    Tsuchihashi, Kazufumi
    Miura, Tetsuji
    HEART AND VESSELS, 2019, 34 (11) : 1789 - 1800
  • [38] Right Ventricular Myocardial Stiffening is Associated With Pulmonary Arterial Stiffening in Pulmonary Hypertension
    Neelakantan, Sunder
    Manning, Edward P.
    Zhang, Peng
    Choudhary, Gaurav
    Avazmohammadi, Reza
    CIRCULATION, 2023, 148
  • [39] Pulmonary hypertension and right ventricular failure. Part X. Prostanoids in the treatment of primary pulmonary arterial hypertension
    Batyraliev, T. A.
    Makhmutkhodzhaev, S. A.
    Ekinci, E.
    Pataraya, S. A.
    Pershukov, I. V.
    Sidorenko, B. A.
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2007, 47 (06) : 70 - 77